← Back to news
NewsCLINICALTRIALS.GOVThursday, February 5, 2026 · February 5, 2026

New recruiting trial: Genetic Aortic Diseases and Cardiovascular Complications. An Observational Survey of Risk Factors.

WHY IT MATTERS

New clinical trials expand access to investigational treatments for rare disease patients.

The aim of this observational study is to define the behavioural and cardiovascular risk factor profiles of patients with genetic aortopathies. The main questions it aims to answer are: * How do the interconnections between lifestyle, stress, psychological condition, perception of illness, and stat

View Trial
Read the original at ClinicalTrials.gov
Clinical TrialRecruitingThoracic Aortic Aneurysm (TAA)

Related conditions

Ehlers-Danlos syndromeLoeys-Dietz syndromeTurner syndromeMarfan syndrome

Related news

ClinicalTrials.gov · April 14, 2026
New recruiting trial: Evaluation of Socio-professional Inclusion for Young Adults Aged 15-25 Living With a Rare Genetic Disability
Rare diseases are often synonymous with difficulties for sufferers, whether physical, mental or social. Patients sufferi
ClinicalTrials.gov · April 13, 2026
New recruiting trial: Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
This study will collect, annotate, and sequence biospecimens (blood, tissue, urine, saliva and surgery drainage) from pa
ClinicalTrials.gov · February 20, 2026
New recruiting trial: FACE.S-4-KIDS : A Deep Phenotyping Database of Craniofacial Anomalies During Development With 4 Pilot Projects
FACE.S-4-KIDS is an ambitious database project addressing the scientific question of the variable expression of craniofa
ClinicalTrials.gov · January 29, 2026
New recruiting trial: Observational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
Background: Primary central nervous system (CNS) tumors grow in the brain and spinal cord. These tumors are rare, but t